시장보고서
상품코드
1262863

세계의 동물용 원료의약품 제조 시장 리포트(2023년)

Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2023

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 200 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 동물용 원료의약품 제조 시장은 2022년 63억 7,000만 달러에서 2023년에는 68억 7,000만 달러로, CAGR 7.8%로 성장할 것으로 예측됩니다. 러시아·우크라이나 전쟁은 적어도 단기적으로는 COVID-19 팬데믹으로부터 세계 경제 회복의 가능성을 혼란시켰습니다. 이 두 국가간 전쟁은 복수 국가에 대한 경제 제재, 상품 가격의 상승, 공급망 혼란으로 이어지며, 상품 및 서비스 전체에 인플레이션을 일으키고, 전 세계의 많은 시장에 영향을 미치고 있습니다. 동물용 원료의약품 제조 시장은 2027년에 CAGR 7.3%로 91억 1,000만 달러로 성장할 것으로 예측됩니다.

2022년 동물용 원료의약품 제조 시장에서는 북미가 최대 지역이 되었습니다. 동물용 원료의약품 제조 시장 리포트의 대상 지역은 아시아태평양, 서유럽, 중유럽 및 동유럽, 북미, 남미, 중동·아프리카입니다.

목차

제1장 주요 요약

제2장 동물용 원료의약품 제조 시장의 특징

제3장 동물용 원료의약품 제조 시장의 동향과 전략

제4장 동물용 원료의약품 제조 시장 - 거시경제 시나리오

  • COVID-19가 동물용 원료의약품 제조 시장에 미치는 영향
  • 우크라이나와 러시아의 전쟁이 동물용 원료의약품 제조 시장에 미치는 영향
  • 고인플레이션이 동물용 원료의약품 제조 시장에 미치는 영향

제5장 동물용 원료의약품 제조 시장 규모와 성장

  • 세계의 동물용 원료의약품 제조 시장의 실적,2017-2022
    • 시장 촉진요인
    • 시장 억제요인
  • 세계의 동물용 원료의약품 제조 시장 예측, 2022-2027F, 2032F
    • 시장 촉진요인
    • 시장 억제요인

제6장 동물용 원료의약품 제조 시장 세분화

  • 세계의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 구충제
  • 항감염증
  • 백신
  • NSAID
  • 세계의 동물용 원료의약품 제조 시장, 서비스 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 인하우스
  • 컨트랙트 아웃소싱
  • 세계의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 화학 기반 API
  • 생물학적 원료의약품
  • 매우 강력한 API

제7장 동물용 원료의약품 제조 시장 지역 및 국가별 분석

  • 세계의 동물용 원료의약품 제조 시장, 지역별, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 세계의 동물용 원료의약품 제조 시장, 국가별, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제8장 아시아태평양의 동물용 원료의약품 제조 시장

  • 아시아태평양의 동물용 원료의약품 제조 시장 개요
  • 지역 정보, COVID-19의 영향, 시장 정보, 배경 정보, 정부 구상, 규제, 규제기관, 주요 단체, 과세되는 세, 법인세 구조, 투자, 주요 기업
  • 아시아태평양의 동물용 원료의약품 제조 시장
  • 아시아태평양의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제9장 중국의 동물용 원료의약품 제조 시장

  • 중국의 동물용 원료의약품 제조 시장 개요
  • 중국의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 중국의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제10장 인도의 동물용 원료의약품 제조 시장

  • 인도의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 인도의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제11장 일본의 동물용 원료의약품 제조 시장

  • 일본의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 일본의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제12장 호주의 동물용 원료의약품 제조 시장

  • 호주의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 호주의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제13장 인도네시아의 동물용 원료의약품 제조 시장

  • 인도네시아의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 인도네시아의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제14장 한국의 동물용 원료의약품 제조 시장

  • 한국의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 한국의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제15장 서유럽의 동물용 원료의약품 제조 시장

  • 서유럽의 동물용 원료의약품 제조 시장 개요
  • 서유럽의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 서유럽의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제16장 영국의 동물용 원료의약품 제조 시장

  • 영국의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 영국의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제17장 독일의 동물용 원료의약품 제조 시장

  • 독일의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 독일의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제18장 프랑스의 동물용 원료의약품 제조 시장

  • 프랑스 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 프랑스의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제19장 동유럽의 동물용 원료의약품 제조 시장

  • 동유럽의 동물용 원료의약품 제조 시장 개요
  • 동유럽의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 동유럽의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제20장 러시아의 동물용 원료의약품 제조 시장

  • 러시아의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 러시아의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제21장 북미의 동물용 원료의약품 제조 시장

  • 북미의 동물용 원료의약품 제조 시장 개요
  • 북미의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 북미의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제22장 미국의 동물용 원료의약품 제조 시장

  • 미국의 동물용 원료의약품 제조 시장 개요
  • 미국의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 미국의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제23장 남미의 동물용 원료의약품 제조 시장

  • 남미의 동물용 원료의약품 제조 시장 개요
  • 남미의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 남미의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제24장 브라질의 동물용 원료의약품 제조 시장

  • 브라질의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 브라질의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제25장 중동의 동물용 원료의약품 제조 시장

  • 중동의 동물용 원료의약품 제조 시장 개요
  • 중동의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 중동의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제26장 아프리카의 동물용 원료의약품 제조 시장

  • 아프리카의 동물용 원료의약품 제조 시장 개요
  • 아프리카의 동물용 원료의약품 제조 시장, 제품별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F
  • 아프리카의 동물용 원료의약품 제조 시장, 합성 유형별 세분화, 실적과 예측, 2017-2022, 2022-2027F, 2032F

제27장 동물용 원료의약품 제조 시장의 경쟁 구도와 기업 개요

  • 동물용 원료의약품 제조 시장의 경쟁 구도
  • 동물용 원료의약품 제조 시장의 기업 개요
    • Alivira Animal Health Limited
    • Excel Industries Limited
    • Ofichem Group
    • Menadiona SL
    • Afton Pharma

제28장 동물용 원료의약품 제조 시장의 주요 합병과 인수

제29장 동물용 원료의약품 제조 시장의 미래 전망과 잠재적 분석

제30장 부록

KSA 23.04.27

“Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary active pharmaceutical ingredients manufacturing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary active pharmaceutical ingredients manufacturing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The veterinary active pharmaceutical ingredients manufacturing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product: Antiparasitic; Anti-Infectives; Vaccines; NSAIDs
  • 2) By Service Type: In House; Contract Outsourcing
  • 3) By Synthesis Type: Chemical Based API; Biological API; Highly Potent API
  • Companies Mentioned: Alivira Animal Health Limited; Excel Industries Limited; Ofichem Group; Menadiona SL; Afton Pharma
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the veterinary active pharmaceutical ingredients manufacturing market are: Alivira Animal Health Limited, Excel Industries Limited, Ofichem Group, Menadiona SL, Afton Pharma, Jiangsu Lingyun Pharmaceutical Co Limited, SUANFARMA, NGL Fine-Chem Limited, FIS - Fabbrica Italiana Sintetici SpA, Lupin Limited, Aurobindo Pharma Limited, Albemarle Corporation, Saneca Pharmaceuticals AS, Neuland Laboratories Limited, and Divi's Laboratories Limited.

The global veterinary active pharmaceutical ingredients manufacturing market is expected to grow from $6.37 billion in 2022 to $6.87 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The veterinary active pharmaceutical ingredients manufacturing market is expected to grow to $9.11 billion in 2027 at a CAGR of 7.3%.

The veterinary active pharmaceutical ingredients manufacturing market consists of revenues earned by entities by biologics and bulk drugs that are used to create components in medications which are responsible for the positive veterinary health impacts. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Veterinary active pharmaceutical ingredients manufacturing refers to API synthesis from raw materials that necessitates multi-step methods using a range of high-tech processing technologies.

North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2022. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main products of veterinary active pharmaceutical ingredients manufacturing are anti-infectives, vaccines, and nsaids. Chemical-based API refers to the active ingredients of pharmaceutical medicine that have the desired impact on the body in order to cure a disease. The various service types involved are in house, and contract outsourcing and various synthetic types involved chemical based API, biological API, and highly potent API.

The increasing pet ownerships are expected to propel the growth of the veterinary active pharmaceutical ingredients manufacturing market going forward. Pet owners are individuals who own or adopt a pet animal. The pet owners provide necessary health facilities to the pets which increases the demand for veterinary drugs. For Instance, according to South China Morning Post, a Hong Kong-based English-language newspaper, pet owners in China reached 62.94 million in 2020 - up from 62.8 million in 2019. Therefore, the increasing pet ownership is driving the demand for the veterinary active pharmaceutical ingredients manufacturing market.

Product innovation is a key trend gaining popularity in the veterinary active pharmaceutical ingredient manufacturing market. Major players in the market are focusing on innovative products to sustain their market position. For instance, in June 2021, Lasa Supergenerics Limited, an India-based veterinary active pharmaceutical ingredients (API) manufacturing company, launched Oxyclozanide. Oxyclozanide is a novel anthelmintic that treats and manages fascioliasis, a topical worm infection in ruminants, primarily domestic animals like cattle (particularly buffalos on farms), goats, and sheep. Oxyclozanide is frequently used in the veterinary industry and has enormous potential in domestic and international markets.

In June 2022, Orion Corporation, a Finland-based human and veterinary pharmaceutical industry, acquired Inovet (V.M.D. nv/sa) for an amount of $128.33 million (130 million euros). Through this acquisition, Orion's Veterinary Medicines section will broaden its product portfolio and obtain a foothold in the production animal market, as well as extend its geographical footprint in Western Europe and the export market. Inovet (V.M.D. nv/sa) is a Belgium-based manufacturer of veterinary active pharmaceutical ingredients.

The countries covered in the veterinary active pharmaceutical ingredients manufacturing market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The veterinary active pharmaceutical ingredients manufacturing market research report is one of a series of new reports from The Business Research Company that provides veterinary active pharmaceutical ingredients manufacturing market statistics, including veterinary active pharmaceutical ingredients manufacturing industry global market size, regional shares, competitors with veterinary active pharmaceutical ingredients manufacturing market share, detailed veterinary active pharmaceutical ingredients manufacturing market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary active pharmaceutical ingredients manufacturing industry. This veterinary active pharmaceutical ingredient manufacturing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Table of Contents

1. Executive Summary

2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Characteristics

3. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Trends And Strategies

4. Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Veterinary Active Pharmaceutical Ingredients Manufacturing Market
  • 4.2. Ukraine-Russia War Impact On Veterinary Active Pharmaceutical Ingredients Manufacturing Market
  • 4.3. Impact Of High Inflation On Veterinary Active Pharmaceutical Ingredients Manufacturing Market

5. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size And Growth

  • 5.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segmentation

  • 6.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Antiparasitic
  • Anti-Infectives
  • Vaccines
  • NSAIDs
  • 6.2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Service Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • In House
  • Contract Outsourcing
  • 6.3. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Chemical Based API
  • Biological API
  • Highly Potent API

7. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Regional And Country Analysis

  • 7.1. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 8.1. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 9.1. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 9.2. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 10.1. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 11.1. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 12.1. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 13.1. Indonesia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 14.1. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 15.1. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 15.2. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 16.1. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 17.1. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 18.4. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.5. France Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 19.1. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 19.2. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 20.1. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 21.1. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 21.2. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 22.1. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 22.2. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 23.1. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 23.2. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 24.1. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 25.1. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 25.2. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market

  • 26.1. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market Overview
  • 26.2. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Veterinary Active Pharmaceutical Ingredients Manufacturing Market, Segmentation By Synthesis Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Landscape And Company Profiles

  • 27.1. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Competitive Landscape
  • 27.2. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Company Profiles
    • 27.2.1. Alivira Animal Health Limited
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Excel Industries Limited
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Ofichem Group
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Menadiona SL
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Afton Pharma
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Veterinary Active Pharmaceutical Ingredients Manufacturing Market

29. Veterinary Active Pharmaceutical Ingredients Manufacturing Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제